Brevan Howard Capital Management’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Sell
23,152
-2,152
-9% -$235K 0.02% 585
2026
Q1
$2.1M Buy
25,304
+20,065
+383% +$1.72M 0.02% 541
2025
Q4
$448K Sell
5,239
-38,973
-88% -$3.26M ﹤0.01% 1169
2025
Q3
$3.69M Buy
44,212
+12,995
+42% +$1.19M 0.02% 321
2025
Q2
$3.16M Buy
+31,217
New +$3.18M 0.02% 551
2024
Q4
– Sell
-9,936
Closed -$1.44M – 1104
2024
Q3
$1.44M Buy
+9,936
New +$1.36M 0.01% 339
2024
Q1
– Sell
-3,140
Closed -$293K – 1058
2023
Q4
$293K Buy
+3,140
New +$290K ﹤0.01% 720

Other funds holding CROX

Brevan Howard Capital Management's CROX Position: Q2 2026 in Review

Brevan Howard Capital Management reduced its Crocs (CROX) stake by 8.5% in Q2 2026, selling an estimated $235K and leaving 23,152 shares worth $2.79M. The position accounts for 0.02% of the portfolio, ranked #585.

Brevan Howard Capital Management first reported a position in CROX in Q4 2023 and has held it in 7 quarters since. The position peaked at $3.69M in Q3 2025. 502 funds tracked by Wall St. Rank hold CROX as of Q2 2026.

  • Brevan Howard Capital Management held 23,152 shares of Crocs worth $2.79M as of Q2 2026.
  • Brevan Howard Capital Management sold 2,152 Crocs shares in Q2 2026, an estimated $235K.
  • Crocs made up 0.02% of Brevan Howard Capital Management's portfolio in Q2 2026, its #585 holding.
  • Brevan Howard Capital Management first reported a position in Crocs in Q4 2023 and has held it in 7 quarters since.
  • Brevan Howard Capital Management's Crocs position peaked at $3.69M in Q3 2025.
  • 502 funds tracked by Wall St. Rank held Crocs as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.